<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-YQHFNOAA</identifier><date>2014</date><creator>Mavri, Alenka</creator><creator>Štalc, Monika</creator><relation>documents/doc/Y/URN_NBN_SI_doc-YQHFNOAA_001.pdf</relation><relation>documents/doc/Y/URN_NBN_SI_doc-YQHFNOAA_001.txt</relation><format format_type="issue">12</format><format format_type="volume">83</format><format format_type="type">article</format><format format_type="extent">str. 849-856</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">2203052</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-YQHFNOAA</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">atrijska fibrilacija</subject><subject language_type_id="slv">dabigatran</subject><subject language_type_id="slv">rivaroksaban</subject><subject language_type_id="slv">venska tromboza</subject><title>Dabigatran and rivaroxaban in the patients with atrial fibrillation and venous thrombembolism</title><title>Dabigatran in rivaroksaban v zdravljenju bolnikov z atrijsko fibrilacijo in vensko trombembolijo</title><title>our first clinical experience</title><title>naše prve klinične izkušnje</title></Record>